share_log

青松股份(300132.SZ)：控股子公司广东可普睿主要从事合成生物技术研发及新材料技术研发

Qingsong Co., Ltd. (300132.SZ): The holding subsidiary Guangdong Coprui is mainly engaged in synthetic biotechnology research and development of new material technology

Gelonghui Finance ·  May 8 19:33

Gelonghui, May 9 | Qingsong Co., Ltd. (300132.SZ) said on the investor interactive platform that the company is mainly engaged in cosmetic ODM business. Some of the company's cosmetic products contain recombinant collagen ingredients. Currently, recombinant collagen raw materials are purchased from third parties, and the sales share of such products is relatively low, which has limited impact on the company's operations. In addition, Guangdong Coprui Biotechnology Co., Ltd., a holding subsidiary of the company, is mainly engaged in synthetic biotechnology research and development of new material technology. Currently, Guangdong Coprui related technology is still in the early stages of R&D, has not generated substantial revenue, and has no impact on the company's short-term operations. Investors are invited to pay attention to risks and invest rationally.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment